Page 54 - Elements CHI New Revised 20200808

参考文献

and alternative medicine 13.1 (2013): 64.
3)Rausch, Wolf-Dieter, et al. “Neuroprotective effects of ginsenosides.” Acta Neurobiol Exp (Wars) 66.4 (2006): 369-375.
4)Reay, Jonathon L., David O. Kennedy, and Andrew B. Scholey. “Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive
performance during sustained mental activity.” Journal of Psychopharmacology 19.4 (2005): 357-365.
5)Reay, Jonathon L., Andrew B. Scholey, and David O. Kennedy. “Panax ginseng (G115) improves aspects of working memory performance and subjective
ratings of calmness in healthy young adults.” Human Psychopharmacology: Clinical and Experimental 25.6 (2010): 462-471.
6)Heo, Jae-Hyeok, et al. “Improvement of cognitive deficit in Alzheimer’s disease patients by long term treatment with Korean red ginseng.” Journal of
ginseng research 35.4 (2011): 457.
7)Jang, Dai‐Ja, et al. “Red ginseng for treating erectile dysfunction: a systematic review.” British journal of clinical pharmacology 66.4 (2008): 444-450.
8)Scaglione, F., et al. “Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and
protection against the common cold [corrected].” Drugs under experimental and clinical research 22)2 (1996): 65-72)
9)Yun, Taik-Koo, and Soo-Yong Choi. “Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs.” Cancer
Epidemiology and Prevention Biomarkers 4.4 (1995): 401-408.
10)Kim, Hyeong-Geug, et al. “Antifatigue effects of Panax ginseng CA Meyer: a randomised, double-blind, placebo-controlled trial.” PloS one 8.4 (2013).
11)Luo, John Zeqi, and Luguang Luo. “Ginseng on hyperglycemia: effects and mechanisms.” Evidence-Based Complementary and Alternative Medicine
6.4 (2009): 423-427.
12)Vuksan, Vladimir, et al. “Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a
randomized, double-blind, placebo-controlled study of efficacy and safety.” Nutrition, Metabolism and Cardiovascular Diseases 18.1 (2008): 46-56.
GABA发芽米
1)Abdou, Adham M., et al. “Relaxation and immunity enhancement effects of γ‐Aminobutyric acid (GABA) administration in humans.” Biofactors 26.3
(2006): 201-208.
2)Byun, Jung-Ick, et al. “Safety and efficacy of gamma-aminobutyric acid from fermented rice germ in patients with insomnia symptoms: A randomized,
double-blind trial.” Journal of Clinical Neurology 14.3 (2018): 291-295.
3)Shimada, Morio, et al. “Anti-hypertensive effect of γ-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension
in placebo-controlled double blind study.” Clinical and experimental hypertension 31.4 (2009): 342-354.
4)Kanehira, Tsutomu, et al. “Relieving occupational fatigue by consumption of a beverage containing γ-amino butyric acid.” Journal of nutritional science
and vitaminology 57.1 (2011): 9-15.
5)Yoto, A., et al. “Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental
tasks.” Amino Acids 43.3 (2012): 1331-1337.
6)Yamatsu, Atsushi, et al. “Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans.” Food science and biotechnology
25.2 (2016): 547-551.
7)Abdou, Adham M., et al. “Relaxation and immunity enhancement effects of γ‐Aminobutyric acid (GABA) administration in humans.” Biofactors 26.3
(2006): 201-208.
8) Winkelman, John W., et al. “Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS).”
Sleep 31.11 (2008): 1499-1506.
昆布萃取物
Zhang, Quanbin, et al. “Effects of fucoidan on chronic renal failure in rats.” Planta medica 69.06 (2003): 537-541.
1)Kim, Min Sun, et al. “Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with
type 2 diabetes mellitus.” Nutrition research and practice 2)2 (2008): 62-67.
2)Wilcox, Matthew D., et al. “The modulation of pancreatic lipase activity by alginates.” Food chemistry 146 (2014): 479-484.
3)Abidov, Musa, et al. “The effects of Xanthigen™ in the weight management of obese premenopausal women with non‐alcoholic fatty liver disease and
normal liver fat.” Diabetes, obesity and metabolism 12)1 (2010): 72-81.
4)Farooqi, Ammad Ahmad, Ghazala Butt, and Zubia Razzaq. “Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers
of ‘the dance macabre’.” Cancer cell international 12)1 (2012): 50.
5)Moussavou, Ghislain, et al. “Anticancer effects of different seaweeds on human colon and breast cancers.” Marine drugs 12)9 (2014): 4898-4911.
6)Wang, Jing, et al. “Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica.” International Journal of Biological
Macromolecules 42)2 (2008): 127-132)
7)Cao, Yin-guang, et al. “Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus.” Biomedicine &
Pharmacotherapy 84 (2016): 1705-1710.
8)Takeuchi, Takako, et al. “Treatment of hypothyroidism due to iodine deficiency using daily powdered kelp in patients receiving long-term total enteral
nutrition.” Clinical Pediatric Endocrinology 20.3 (2011): 51-55.
9)Mori, Naoki, et al. “Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection.” World journal of gastroenterology: WJG 18.18
(2012): 2225.
10)Hayashi, Kyoko, et al. “Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection.” International
immunopharmacology 8.1 (2008): 109-116.
11)Kim, Beom‐Su, et al. “Fucoidan‐induced osteogenic differentiation promotes angiogenesis by inducing vascular endothelial growth factor secretion and
accelerates bone repair.” Journal of tissue engineering and regenerative medicine 12)3 (2018): e1311-e1324.
12)Wang, Jing, et al. “Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease.”
Journal of ethnopharmacology 139.3 (2012): 807-813.
13)Zhang, Quanbin, et al. “Effects of fucoidan on chronic renal failure in rats.” Planta medica 69.06 (2003): 537-541.
水飞蓟宾
1)Ward, Jeanine, et al. “Amatoxin poisoning: case reports and review of current therapies.” The Journal of emergency medicine 44.1 (2013): 116-121.
2)Federico, Alessandro, Marcello Dallio, and Carmelina Loguercio. “Silymarin/silybin and chronic liver disease: a marriage of many years.” Molecules 22)2
(2017): 191.
3)Polachi, Navaneethakrishnan, et al. “Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer–A comprehensive
review.” European journal of medicinal chemistry 123 (2016): 577-595.
4)Vargas-Mendoza, Nancy, et al. “Hepatoprotective effect of silymarin.” World journal of hepatology 6.3 (2014): 144.
5)Kumar, Amit, et al. “Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental
dementia.” Naunyn-Schmiedeberg’s archives of pharmacology 387.8 (2014): 777-787.
6)Pérez-Hernández, Jesús, et al. “A potential alternative against neurodegenerative diseases: Phytodrugs.” Oxidative medicine and cellular longevity 2016
(2016).
7)Kim, Jung-Lye, et al. “Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.” BioMed
research international 2013 (2013).
8)Sahib, A. S., et al. “Effects of oral antioxidant lesion counts associated with oxidative stress and inflammation in patients with papulopustular acne.” J
Clin Exp Dermatol Res 3.5 (2012): 1-6.
9)Voroneanu, Luminita, et al. “Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.” Journal of
diabetes research 2016 (2016).
10)Bosch-Barrera, Joaquim, Bernardo Queralt, and Javier A. Menendez. “Targeting STAT3 with silibinin to improve cancer therapeutics.” Cancer treatment
reviews 58 (2017): 61-69.
11)Davis-Searles, Paula R., et al. “Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end
points in human prostate carcinoma cells.” Cancer research 65.10 (2005): 4448-4457.
54